Cargando…

An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases

Detalles Bibliográficos
Autores principales:	Ghany, Marc G, Nelson, David R, Strader, Doris B, Thomas, David L, Seeff, Leonard B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Subscription Services, Inc., A Wiley Company 2011
Materias:	AASLD Practice Guideline
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229841/ https://www.ncbi.nlm.nih.gov/pubmed/21898493 http://dx.doi.org/10.1002/hep.24641

Ejemplares similares

Diagnosis and Management of Hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases
por: Bacon, Bruce R, et al.
Publicado: (2011)

Management of hepatocellular carcinoma: An update
por: Bruix, Jordi, et al.
Publicado: (2011)

Introduction to the Revised American Association for the Study of Liver Diseases Position Paper on Acute Liver Failure 2011
por: Lee, William M, et al.
Publicado: (2012)

Mo1330: THE IMPACT OF COVID-19 ON ALCOHOLIC LIVER DISEASES IN A PREDOMINANTLY AFRICAN AMERICAN AND HISPANIC COMMUNITY
por: Sun, Haozhe, et al.
Publicado: (2022)

Updated clinical guideline for human papillomavirus vaccine: the Korean Society of Gynecologic Oncology guidelines
por: Cho, Hyun-Woong, et al.
Publicado: (2021)

SASLT practice guidelines for the management of Hepatitis B virus – An update
por: Abaalkhail, Faisal A., et al.
Publicado: (2021)

Su325 HEPATIC STEATOSIS MAY LEAD TO WORSE OUTCOMES IN PATIENTS WITH LIVER INJURY AND COVID-19
por: Shaikh, Danial H., et al.
Publicado: (2021)

Updated guideline for closure of abdominal wall incisions from the European and American Hernia Societies
por: Deerenberg, Eva B, et al.
Publicado: (2022)

310 Ribavirin coupled to hemoglobin protects against viral hepatitis induced by the corona virus MHV-3 in mice
por: Levy, Gary A., et al.
Publicado: (2003)

Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update)
por: Hou, Jinlin, et al.
Publicado: (2017)

Su318 PATTERNS OF LIVER TRANSPLANTATION EVALUATIONS FOR HOSPITALIZED ADULTS WITH ACUTE ALCOHOLIC HEPATITIS DURING COVID-19: A SINGLE CENTER STUDY
por: Bangaru, Saroja, et al.
Publicado: (2021)

Su316 INCREASED DIAGNOSIS OF HEPATOCELLULAR CARCINOMA IN HOSPITALIZED PATIENTS WITH ALCOHOL RELATED HEPATITIS AFTER THE COVID-19 OUTBREAK: A GLOBAL MULTI-CENTER PROPENSITY MATCHED ANALYSIS.
por: Perisetti, Abhilash, et al.
Publicado: (2021)

Su322 SEVERE CHOLESTATIC HEPATITIS SECONDARY TO SARS-COV-2
por: Lindholm, Christopher R., et al.
Publicado: (2021)

Tu1261: IMPACT OF THE COVID-19 PANDEMIC ON THE EPIDEMIOLOGY OF ALCOHOL-ASSOCIATED HEPATITIS
por: Frolkis, Alexandra, et al.
Publicado: (2022)

Tu1266: VARIABLE IMPACT OF COVID-19 PANDEMIC ON HOSPITALIZATION FOR ALCOHOL-ASSOCIATED LIVER DISEASE.
por: Lee, Tai-Ping, et al.
Publicado: (2022)

Tu1257: AUTOIMMUNE HEPATITIS FOLLOWING COVID-19 VACCINATION: A SYSTEMATIC REVIEW OF THE LITERATURE
por: Chow, Kenneth W., et al.
Publicado: (2022)

Tu1256: METFORMIN USE IS ASSOCIATED WITH LESS FREQUENT SEVERE LIVER INJURY UPON HOSPITAL ADMISSIN WITH COVID-19
por: Kuntzen, Christian, et al.
Publicado: (2022)

EP1194: THE PROGNOSTIC IMPLICATIONS OF LIVER FUNCTION TEST ABNORMALITIES IN PATIENTS ADMITTED TO HOSPITAL WITH COVID-19
por: Cohen, Jason, et al.
Publicado: (2022)

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
por: Sarin, S. K., et al.
Publicado: (2015)

EP1193: A NOVEL PROGNOSTIC MODEL INCLUDING LIVER FUNCTION PARAMETERS ACCURATELY PREDICTS 30-DAY MORTALITY IN PATIENTS ADMITTED WITH COVID-19
por: Lee, David U., et al.
Publicado: (2022)

Sa1390: THE EFFICACY OF ELBASVIR/GRAZOPREVIR FIXED-DOSE COMBINATION FOR 8 WEEKS IN HCV TREATMENT AND HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN TREATMENT-NAIVE, NON-CIRRHOTIC, GENOTYPE 4-INFECTED PATIENTS (ELEGANT-4)
por: AlEid, Ahmad, et al.
Publicado: (2022)

Tu1254: SARS-COV-2 VACCINATION HESITANCY AND RISK OF DISEASE FLARE ARE BOTH LOW AMONG AN AUTOIMMUNE HEPATITIS PATIENT COHORT
por: Chalasani, Sai, et al.
Publicado: (2022)

The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
por: Percie du Sert, Nathalie, et al.
Publicado: (2020)

Vestibular Rehabilitation for Peripheral Vestibular Hypofunction: An Updated Clinical Practice Guideline From the Academy of Neurologic Physical Therapy of the American Physical Therapy Association
por: Hall, Courtney D., et al.
Publicado: (2022)

Su320 A RETROSPECTIVE ANALYSIS OF OUTCOMES AMONGST COVID-19 PATIENTS WITH ACUTE HEPATITIS RECEIVING N-ACETYLCYSTEINE THERAPY IN A SAFETY NET HOSPITAL
por: Pellegrini, James R., et al.
Publicado: (2021)

Sa1389: LESSONS FROM HEPATITIS C TREATMENT DURING THE COVID-19 PANDEMIC: DECREASED RESOURCE UTILIZATION LEADS TO SIMILAR EFFICACY IN BRITISH COLUMBIA, CANADA
por: Jiang, Shirley X., et al.
Publicado: (2022)

American Telemedicine Association clinical guidelines for telepathology
por: Pantanowitz, Liron, et al.
Publicado: (2014)

Tu1270: SEROLOGICAL RESPONSE TO SARS-COV-2 VACCINES IN LIVER TRANSPLANT PATIENTS
por: Toapanta-Yanchapaxi, Liz, et al.
Publicado: (2022)

Tu1267: TELEMEDICINE DURING COVID-19 PANDEMIC IS AN ACCEPTABLE MODALITY FOR LIVER CARE DELIVERY IN VULNERABLE POPULATIONS WITH FATTY LIVER DISEASE
por: Khalili, Mandana, et al.
Publicado: (2022)

784: THE IMPACT OF THE CORONAVIRUS PANDEMIC AND GOVERNMENT LOCKDOWNS ON LIVER DISEASE HOSPITALIZATIONS, INPATIENT MORTALITY, AND LIVER TRANSPLANT SURGERY IN CALIFORNIA: A POPULATION-LEVEL ANALYSIS
por: Adekunle, Ayooluwatomiwa D., et al.
Publicado: (2022)

Update of the international HerniaSurge guidelines for groin hernia management
por: Stabilini, Cesare, et al.
Publicado: (2023)

Tu1260: IMPACT OF COVID-19 ON PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS
por: Moga, Tudor V., et al.
Publicado: (2022)

Liver Transplant Society of India Guidelines for Liver Transplant During COVID-19 times
por: Gupta, Subash, et al.
Publicado: (2022)

10 IMPACT OF CHRONIC LIVER DISEASE ON THE COVID-19 HOSPITAL ADMITTED PATIENTS
por: Amjad, Waseem, et al.
Publicado: (2021)

Tu1265: LIVER INJURY IN HOSPITALIZED COVID-19 PATIENTS TREATED WITH TOCILIZUMAB
por: Kalligeros, Markos, et al.
Publicado: (2022)

EP1195: COVID-19 INFECTION AND BREAKTHROUGH INFECTION IN POST LIVER TRANSPLANT PATIENTS
por: Moein, Hamid-Reza, et al.
Publicado: (2022)

Su324 THE IMPACT OF THE COVID-19 PANDEMIC ON LIVER BIOMARKERS AND QUALITY OF LIFE IN PATIENTS WITH NAFLD
por: Clarke, Lindsay M., et al.
Publicado: (2021)

EP1192: LIVER TEST ABNORMALITIES IN COVID-19 PATIENTS MAY NOT BE RELATED TO CYTOKINE STORM
por: Piskorz, Maria, et al.
Publicado: (2022)

Mo1336: PREVALENCE AND MORTALITY OF ALCOHOL-RELATED LIVER DISEASES DURING COVID-19 PANDEMIC
por: Yeo, Yee Hui, et al.
Publicado: (2022)

Su1373: UTILIZATION OF DRUG OVERDOSE DONORS FOR LIVER TRANSPLANTATION DURING COVID-19 PANDEMIC
por: Lymberopoulos, Peter, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3n5trafg3tns38uu0n4ru3o46o